Magnetic source imaging developer Biomagnetic Technologies ofSan Diego reported a lower net loss for its first quarter of 1997(end-December), due to lower R&D costs. Revenues for the quarterwere up slightly, but did not include any systems sales
Magnetic source imaging developer Biomagnetic Technologies ofSan Diego reported a lower net loss for its first quarter of 1997(end-December), due to lower R&D costs. Revenues for the quarterwere up slightly, but did not include any systems sales becausethe company is still awaiting the completion of a hardware upgradebefore it can record revenue from eight installations of its newMagnes 2500 Whole Head system.
For the quarter, BTI posted revenue of $317,000, compared with$195,000 in the same period the year before. The firm's net lossfor the most recent quarter stood at $2.1 million, compared with$3.1 million in the first quarter of 1996.
BTI has been hit hard by a delay in shipments of its Magnes 2500WH system, and was forced to restructure in December as a meansof conserving cash until it begins recognizing revenue from Magnesshipments (SCAN 2/5/97). That will happen once final customeracceptances are received following the installation of a hardwareupgrade that was not anticipated at the time of shipment, accordingto the company.
There are eight Magnes 2500 WH systems installed worldwide, andBTI's backlog as of Dec. 31 stood at $16.2 million, compared with$12.1 million the year before.
What a New Meta-Analysis Reveals About PET/CT Radiotracers for csPCa
February 6th 2025The PET/CT agent 18F-PSMA-1007 offered the highest surface under the cumulative ranking curve (SUCRA) out of nine radiotracers at the patient and lesion level for detecting clinically significant prostate cancer (csPCa), according to a meta-analysis.
New CT Angiography Study Shows Impact of COVID-19 on Coronary Inflammation and Plaque
February 5th 2025Prior COVID-19 infection was associated with a 28 percent higher progression of total percent atheroma volume (PAV) annually and over a 5 percent higher incidence of high-risk plaque in patients with coronary artery lesions, according to CCTA findings from a new study.